The U.S. Food and Drug Administration (”FDA”) announced the approval of EVOLENCE® for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. EVOLENCE® is a new advanced collagen-based structural dermal filler, and a first of its kind product. The introduction of EVOLENCE® marks the first dermal filler entry for the Aesthetics Group of OrthoNeutrogena.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 4th, 2008 under skin health.
Comments: none